These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib. Wang WC, Crist WM, Ihle JN, Arnold BA, Keating JP. Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246 [Abstract] [Full Text] [Related]
3. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient. Gordon MS, O'Donnell JA, Mohler ER, Cooper MA. J Heart Lung Transplant; 1993 Apr; 12(4):706-7. PubMed ID: 7690254 [Abstract] [Full Text] [Related]
4. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Fazio MT, Glaspy JA. Oncol Nurs Forum; 1991 Apr; 18(8):1411-4. PubMed ID: 1722310 [Abstract] [Full Text] [Related]
9. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias]. Martínez Ruiz M, Llobell Segui G, Peralba Vaño JI, Toral Revuelta JR, Mellado del Rey F, González de Aledo GB. An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082 [No Abstract] [Full Text] [Related]
10. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K. Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210 [Abstract] [Full Text] [Related]
13. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis. Cernelc P, Andoljsek D, Mlakar U, Pretnar J, Modic M, Zupan IP, Zver S. Pflugers Arch; 2000 Feb; 440(5 Suppl):R81-2. PubMed ID: 11005621 [Abstract] [Full Text] [Related]